Helen Sabzevari
Chief Executive Officer bei PRECIGEN, INC.
Vermögen: 3 Mio $ am 31.03.2024
Profil
Helen Sabzevari was the founder and Chief Scientific Officer at Compass Therapeutics LLC, which was founded in 2015.
She held this position from 2015 to 2017.
She is currently the President, Chief Executive Officer & Director at Precigen, Inc. since 2020 and the President at PGEN Therapeutics, Inc. since 2017.
Dr. Sabzevari has also served as an Independent Director at Kinnate Biopharma, Inc. from 2021 to 2024.
In addition, she was the Senior Vice President-Health Therapeutics at Precigen, Inc. in 2017 and the Global Head-Immunotherapy, Oncology & Research at EMD Serono, Inc. from 2008 to 2014.
Dr. Sabzevari holds a doctorate degree from The Scripps Research Institute.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
PRECIGEN INC
0,89% | 05.04.2024 | 2 221 076 ( 0,89% ) | 3 Mio $ | 31.03.2024 |
KINNATE BIOPHARMA, INC.
-.--% | 03.04.2024 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Helen Sabzevari
| Unternehmen | Position | Beginn |
|---|---|---|
| PRECIGEN, INC. | Chief Executive Officer | 01.01.2020 |
PGEN Therapeutics, Inc.
 PGEN Therapeutics, Inc. BiotechnologyHealth Technology Part of Precigen, Inc., PGEN Therapeutics, Inc. develops gene and cellular therapies. The private company is based in Henrico, MD. | President | 01.11.2017 |
Ehemalige bekannte Positionen von Helen Sabzevari
| Unternehmen | Position | Ende |
|---|---|---|
| KINNATE BIOPHARMA INC. | Director/Board Member | 03.04.2024 |
| PRECIGEN, INC. | Corporate Officer/Principal | 01.11.2017 |
Compass Therapeutics LLC
 Compass Therapeutics LLC BiotechnologyHealth Technology Compass Therapeutics LLC operates as a healthcare industry focusing on biotechnology. It offers drug discovery, development, biologics, oncology and immuno-oncology. The company was founded by Errik B. Anderson and Thomas J. Schuetz in 2014 and is headquartered in Cambridge, MA. | Founder | 01.01.2017 |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Chief Tech/Sci/R&D Officer | 01.01.2014 |
Ausbildung von Helen Sabzevari
| The Scripps Research Institute | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| PRECIGEN, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Compass Therapeutics LLC
Compass Therapeutics LLC BiotechnologyHealth Technology Compass Therapeutics LLC operates as a healthcare industry focusing on biotechnology. It offers drug discovery, development, biologics, oncology and immuno-oncology. The company was founded by Errik B. Anderson and Thomas J. Schuetz in 2014 and is headquartered in Cambridge, MA. | Health Technology |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
PGEN Therapeutics, Inc.
PGEN Therapeutics, Inc. BiotechnologyHealth Technology Part of Precigen, Inc., PGEN Therapeutics, Inc. develops gene and cellular therapies. The private company is based in Henrico, MD. | Health Technology |
Kinnate Biopharma, Inc.
 Kinnate Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Kinnate Biopharma, Inc. operates as a biopharmaceutical company engaged in the research and development of Kinnate Discovery Engine that targets genomic drivers of cancer. The company was founded by Stephen W. Kaldor and Eric A. Murphy in January 2018 and is headquartered in San Diego, CA. | Health Technology |
